Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.

@article{Jones2008ExpertPR,
  title={Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.},
  author={Peter Jh Jones},
  journal={The American journal of cardiology},
  year={2008},
  volume={102 12A},
  pages={41L-47L}
}
Even with optimal statin therapy, many patients with type 2 diabetes mellitus or metabolic syndrome fail to achieve all lipid targets and remain at high risk of cardiovascular events. Add-on lipid-modifying therapy that is effective in improving the triglyceride and high-density lipoprotein (HDL) cholesterol abnormalities characteristic of these conditions is a recommended approach to reduce this risk. Fibrates or niacin is a logical option, supported by clinical studies showing improved lipid… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Therapeutic advances in chronic disease • 2011
View 7 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…